GENEVA, June 25 -- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (National Institutes of HealthOffice of Technology Transfer6701 Rockledge Drive, Suite 700, MSC 7788Bethesda, Maryland 20892-7788), REGULONIX LLC (14 Park RoadShort Hills, New Jersey 07078) filed a patent application (PCT/US2024/060335) for "INHIBITORS OF THE SURFACE EXPRESSION OF THE VOLTAGE-GATED SODIUM ION CHANNEL 1.7 (NAV1.7) AND THEIR THERAPEUTIC USES" on Dec 16, 2024. With publication no. WO/2025/129167, the details related to the patent application was published on Jun 19, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intel...